Sellas Life Sciences' pre-market stock price soared by 300% due to cancer trial data
BlockBeats cites BIT's stock platform data, stating that Sellas Life Sciences' pre-market price increased by 300% due to cancer trial results.
Loading…
Connect scattered updates into a story you can understand.
BlockBeats cites BIT's stock platform data, stating that Sellas Life Sciences' pre-market price increased by 300% due to cancer trial results.